(Reuters) – The Biden administration is exploring each solution for rising production of Johnson & Johnson’s COVID-19 vaccine, which is underneath regulatory review, and claimed on Friday that currently expected amounts of early doses were less than hoped. FILE Photo: Vials with a sticker examining, “COVID-19 / Coronavirus vaccine / […]
Thursday, Aug 18, 2022
Breaking News